On June 23, a federal court upheld the Trump Administration’s 2020 Price Transparency Rule, which would require hospitals to disclose their charges and payer-specific negotiated rates for all services they provide.

Yet, many questions remain regarding what provider executives need to do next to prepare for the rule, including:

• Is the rule settled and will there be an appeal?
• What does compliance with the rule look like and what are consequences of non-compliance?
• How might this affect hospital pricing strategies and overall market dynamics?
• Will COVID-19-related utilization changes impact price transparency?

Join experts from Guidehouse’s Managed Care and Pricing Strategy team for a complementary webinar regarding the critical next steps for hospital finance executives as the price transparency rule evolves.

Christopher Kalkhof, Partner

Jeff Leibach, Director

Jeffrey Meyers, Director and former New Hampshire Health and Human Services Commissioner